As shown in Figure 4A, the tumor formed by C6 glioma cells was enhanced in TNFR2−/− mice treated LPS, when compared to those examined in LPS-treated WT or LPS-treated TNFR2+/− mice. Here, TNFRSF1B is linked to glioma.